Beam Therapeutics Inc. — Investor Relations & Filings
Filings indexed
457
across all filing types
Latest filing
2026-05-07
Interim / Quarterly Rep…
Country
US
United States of America
Listing
US
BEAM
Beam Therapeutics Inc. is a biotechnology company developing precision genetic medicines using its proprietary base editing technology. This approach is designed to make precise, single-letter edits to the genome without causing double-stranded breaks in the DNA, aiming to overcome the limitations of traditional gene editing methods. The company's pipeline focuses on creating potential life-long cures for genetic disorders, including sickle cell disease, beta-thalassemia, and alpha-1 antitrypsin deficiency. Beam Therapeutics is also advancing a suite of delivery technologies, such as electroporation, nonviral, and viral modalities, to deliver its base editors to target cells.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 10-Q - Beam Therapeutics Inc. (0001745999) (Filer) | 2026-05-07 | English | |
| 8-K - Beam Therapeutics Inc. (0001745999) (Filer) | 2026-05-07 | English | |
| 4 - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-26 | English | |
| 10-K - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-24 | English | |
| 8-K - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-24 | English | |
| 8-K - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-12 | English |
Browse filings by year
9 years| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2026
15 filings
| |||||
| 42856048 | 10-Q - Beam Therapeutics Inc. (0001745999) (Filer) | 2026-05-07 | English | ||
| 42839540 | 8-K - Beam Therapeutics Inc. (0001745999) (Filer) | 2026-05-07 | English | ||
| 32897641 | 4 - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-26 | English | ||
| 32897644 | 10-K - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-24 | English | ||
| 32897643 | 8-K - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-24 | English | ||
| 32897642 | 8-K - BEAM THERAPEUTICS INC. (0001745999) (Filer) | 2026-02-12 | English | ||
| 31565977 | 8-K Filing | 2026-02-05 | English | ||
| 31565880 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 31565850 | SCHEDULE 13G/A Filing | 2026-02-05 | English | ||
| 31565839 | SCHEDULE 13G/A Filing | 2026-02-03 | English | ||
| 31565975 | 4 Filing | 2026-02-02 | English | ||
| 31565941 | 4 Filing | 2026-02-02 | English | ||
| 31565868 | 4 Filing | 2026-02-02 | English | ||
| 31565847 | 4 Filing | 2026-02-02 | English | ||
| 31565819 | 4 Filing | 2026-02-02 | English | ||
Market data
Market data not available
Last price
Market cap
volume
Day range
today
52-week range
trailing
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Ajanta Pharma Ltd.
Specialty pharmaceutical firm focused on complex generics a…
|
AJANTPHARM | IN | Manufacturing |
|
Akari Therapeutics Plc
Develops next-gen antibody-drug conjugates using proprietar…
|
AKTX | US | Manufacturing |
|
Akebia Therapeutics, Inc.
A biopharmaceutical company that develops and commercialize…
|
AKBA | US | Manufacturing |
|
Akeso, Inc.
Global commercial-stage biopharma developing innovative ant…
|
9926 | KY | Manufacturing |
|
Aktis Oncology, Inc.
A clinical-stage biotech developing targeted alpha radiopha…
|
AKTS | US | Manufacturing |
|
Akums Drugs and Pharmaceuticals Limited
CDMO providing end-to-end pharmaceutical manufacturing and …
|
AKUMS | IN | Manufacturing |
|
Albert David Ltd.
Produces pharmaceutical formulations, infusions, and specia…
|
ALBERTDAVD | IN | Manufacturing |
|
Aldeyra Therapeutics, Inc.
Develops medications for immune-mediated ocular and systemi…
|
ALDX | US | Manufacturing |
|
Aleafia Health Inc.
Vertically integrated cannabis company with cultivation, pr…
|
AH | CA | Manufacturing |
|
Alector, Inc.
Clinical-stage biotech using immuno-neurology to treat neur…
|
ALEC | US | Manufacturing |
Beam Therapeutics Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/31533/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=31533 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=31533 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
Full reference: API reference · OpenAPI schema
cURL
$ curl https://api.financialreports.eu/api/filings/?company=31533 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 31533}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Beam Therapeutics Inc. (id: 31533)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.
We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.